DocGo (NASDAQ:DCGO) Given Buy Rating at Needham & Company LLC

DocGo (NASDAQ:DCGO)‘s stock had its “buy” rating reissued by investment analysts at Needham & Company LLC in a research note issued on Wednesday, Benzinga reports.

Other research analysts also recently issued research reports about the stock. Canaccord Genuity Group restated a “hold” rating and set a $1.00 price target on shares of DocGo in a report on Tuesday, August 18th. Weiss Ratings reissued a “sell (e+)” rating on shares of DocGo in a research report on Monday, September 14th. Three research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus target price of $2.38.

DocGo Stock Performance

Shares of NASDAQ DCGO traded up $0.03 during trading hours on Wednesday, hitting $0.40. The stock had a trading volume of 640,667 shares, compared to its average volume of 884,353. The firm’s 50-day moving average price is $0.48 and its two-hundred day moving average price is $0.56. DocGo has a 52 week low of $0.31 and a 52 week high of $1.65. The company has a market capitalization of $39.55 million, a P/E ratio of -0.20 and a beta of 0.94.

DocGo (NASDAQ:DCGO) last issued its quarterly earnings data on Monday, August 17th. The company reported ($0.16) earnings per share for the quarter, missing the consensus estimate of ($0.10) by ($0.06). The business had revenue of $73.42 million for the quarter, compared to the consensus estimate of $75.35 million. DocGo had a negative net margin of 65.29% and a negative return on equity of 40.42%. As a group, analysts expect that DocGo will post -0.22 EPS for the current fiscal year.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently bought and sold shares of the company. S Squared Technology LLC bought a new position in shares of DocGo in the second quarter worth about $1,060,725. Renaissance Technologies LLC boosted its stake in DocGo by 167.1% during the 1st quarter. Renaissance Technologies LLC now owns 1,510,361 shares of the company’s stock valued at $950,000 after purchasing an additional 944,826 shares during the period. BlackRock Inc. bought a new stake in DocGo during the 2nd quarter valued at approximately $750,000. Isthmus Partners LLC grew its holdings in DocGo by 14.0% in the 1st quarter. Isthmus Partners LLC now owns 1,013,056 shares of the company’s stock valued at $637,000 after buying an additional 124,211 shares during the last quarter. Finally, GSA Capital Partners LLP acquired a new stake in DocGo in the 2nd quarter valued at approximately $517,000. Institutional investors and hedge funds own 56.44% of the company’s stock.

About DocGo

DocGo Inc (NASDAQ: DCGO) is a healthcare services and technology company that delivers medical care and transportation outside traditional clinical settings. Its platform combines mobile clinical services, technology-enabled care coordination and non-emergency medical transportation to help healthcare providers, government agencies, insurers and employers serve patients in their homes and communities.

The company’s services include ambulance and non-emergency medical transportation, mobile primary and urgent care, remote patient monitoring, diagnostic testing, vaccination programs and community-based healthcare.